Berenberg analyst Luisa Hector raised the firm’s price target on AstraZeneca to 13,000 GBp from 12,000 GBp and keeps a Buy rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca Advances in Gene Therapy with Cellectis Stake
- Cellectis announces completion of $140M investment from AstraZeneca
- AstraZeneca’s Calquence Shows Promise in Lymphoma Trial
- AstraZeneca announces results from interim analysis of ECHO Phase III trial
- AstraZeneca put volume heavy and directionally bearish